摘要
目的分析无肌病皮肌炎相关机化性肺炎(ADM-OP)患者临床特点和治疗反应。方法回顾2014年6月至2018年6月于我院住院的8例ADM-OP临床资料,并与同期收治的9例隐源性机化性肺炎(COP)进行比较。结果 ADM-OP出现皮肤改变、Gottron征、技工手及抗合成酶抗体阳性分别为87.5%、75.0%、87.5%及62.5%。与COP相比,ADM-OP在性别、吸烟、呼吸系统症状体征、动脉血氧分压、动脉血二氧化碳分压及治疗方案无差异,发病年龄和入院胸部CT纤维化评分存在差异。治疗3个月胸部CT纤维化评分和变化率、用力肺活量存在差异,治疗6个月胸部CT纤维化评分和变化率、用力肺活量、肺一氧化碳弥散量存在差异。结论ADM-OP患者以皮肤改变、Gottron征、技工手及抗合成酶抗体阳性表现多见,对治疗反应好,影像和肺功能改善速度较COP患者缓慢。
Objective To analyze the clinical characteristics of patients with amyopathic dermatomyositis with organizing pneumonia(ADM-OP). Methods The clinical data of 8 patients hospitalized with ADM-OP from June 2014 to June 2018 were retrospectively reviewed and simultaneously compared with those of 8 patients of cryptogenic organizing pneumonia(COP). Results The incidence of skin lesion, Gottron's sign, mechanic's hand and positive anti-synthase antibodies in the ADM-OP patients were 87.5%, 87.5% 75.0% and 87.5% respectively. Gender, smoking,respiratory symptoms and signs, arterial partial pressure of oxygen, arterial partial pressure of carbon dioxide and treatment strategy were no statistical difference between ADM-OP and COP patients, but the onset age and Chest CT fibrosis scores(CTFS) on admission existed differences. After treatment for 3 months, CTFS, rate of change and forced vital capacity(FVC) existed differences. After treatment for 6 months, CTFS, rate of change, FVC and diffusing capacity of the lung for carbon monoxide existed differences. Conclusions Skin lesion, Gottron's sign, mechanic's hand and positive anti-synthase antibodies are more common in ADM-OP patients. Their response to treatment is good but the improvement rates in CTFS and pulmonary function are slower than those of COP patients.
引文
1 Sontheimer RD. Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis. Curr Opin Rheumatol, 1999, 11(6):475-482.
2韩磊,吕良敬.无肌病性皮肌炎的研究进展.中华风湿病学杂志,2011,15(11):795-797.
3 Sun Y, Liu Y, Yan B, et al. Interstitial lung disease in clinically amyopathic dermatomyositis(CADM)patients:a retrospective study of 41 Chinese Han patients. Rheumatol Int, 2013, 33(5):1295-1302.
4 Li XR, Peng SC, Wei LQ. Nonspecific interstitial pneumonia overlaps organizing pneumonia in lung-dominant connective tissue disease. Int J Clin Exp Pathol, 2015, 8(9):11230-11235.
5中华医学会风湿病学分会.多发性肌炎和皮肌炎诊断及治疗指南.中华风湿病学杂志,2010, 14(12):828-831.
6 Bradley B, Branley HM, Egan JJ, et al. Interstitial Lung Disease Guideline:the British Thoracic Society in Collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax, 2008,63(Suppl 5):vl-v58.
7 Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society Statement:Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med,2013,188(6):733-748.
8 Lynch DA, Godwin JD, Safrin S, et al. High-resolution computed tomography in idiopathic pulmonary fibrosis:diagnosis and prognosis. Am J Respir Crit Care Med, 2005, 172(4):488-493.
9徐凌,沈策.机化性肺炎的研究进展.国际呼吸杂志,2007, 27(24):1903-1906.
10董馨,郑毅,王丽,等.结缔组织病相关性机化性肺炎的临床特点.中华风湿病学杂志,2015, 19(6):374-379.
11沈敏,龚瑜林,曾小峰,等.以间质性肺疾病起病的皮肌炎临床特点分析.中华医学杂志,2014, 94(43):3402-3406.
12 Hayashi S, Tanaka M, Kobayashi H, et al. High-resolution computed tomography characterization of interstitial lung diseases in polymyositis/dermatomyositis. J Rheumatol, 2008, 35(2):260-269.
13 Tsuchiya Y, Fischer A, Solomon JJ, et al. Connective tissue diseaserelated thoracic disease. Clin Chest Med, 2015, 36(2):283-297.